Biogen Idec submits application to FDA for first long-lasting factor IX therapy for Hemophilia B
4 January 2013 | By Biogen Idec
Half-life of long-lasting rFIXFc may enable prophylactic dosing every 1-2 weeks...
List view / Grid view
News
Biogen Idec reports top-line results from Phase 3 trial
3 January 2013 | By Biogen Idec
EMPOWER trial fails to demonstrate efficacy in primary and key secondary endpoints...
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
3 January 2013 | By EMD Serono; Pfizer Inc.
The majority of patients found Rebif Rebidose easy to use in a user trial...
Abbott announces FDA approval and U.S. launch of next-generation XIENCE Xpedition™ drug eluting stent system
3 January 2013 | By Abbott
FDA approval - XIENCE Xpedition™ Everolimus Eluting Coronary Stent System...
U.S. FDA Approves ELIQUIS® (apixaban)
2 January 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Pfizer announced that the U.S. FDA approved ELIQUIS® (apixaban)...
FDA acknowledgement of resubmission of New Drug Application for Ezetimibe/Atorvastatin tablets
2 January 2013 | By Merck
FDA has acknowledged the resubmission of a New Drug Application...
Abbott completes separation of research-based pharmaceuticals business
2 January 2013 | By Abbott
Abbott has completed the separation of its research-based pharmaceuticals business...
FDA grants accelerated approval for SIRTURO™ (bedaquiline)
31 December 2012 | By Johnson & Johnson
FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis...
ELIQUIS® (apixaban) approved in Japan
26 December 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb and Pfizer Inc. announced that the Japanese Ministry of Health, Labor and Welfare has approved ELIQUIS® (apixaban)...
Ryzodeg® (insulin degludec/insulin aspart) approved in Japan
25 December 2012 | By Novo Nordisk
Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg®...
Roche announces FDA approval of Tamiflu for the treatment of influenza in infants
22 December 2012 | By Roche
First medicine approved to treat influenza in infants two weeks of age and older...
Novartis drug Exjade® approved by European Commission for iron overload in patients with non-transfusion-dependent thalassemia
21 December 2012 | By Novartis
The EC has approved Exjade®...
Biogen Idec forms first-of-its-kind research consortium to identify ALS drug targets
20 December 2012 | By Biogen Idec
Biogen Idec has created a new research consortium...
Top-line six-month primary treatment period results from first Phase III Fabry monotherapy study
19 December 2012 | By GlaxoSmithKline
Six-month primary treatment period results...
The final phase 3a trial for IDegLira completed, and FIAsp approved for phase 3 development
19 December 2012 | By Novo Nordisk
Novo Nordisk announced the completion of the phase 3a programme for IDegLira...
